These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36265088)

  • 61. Not all false positive diagnoses are equal: On the prognostic implications of false-positive diagnoses made in breast MRI versus in mammography / digital tomosynthesis screening.
    Kuhl CK; Keulers A; Strobel K; Schneider H; Gaisa N; Schrading S
    Breast Cancer Res; 2018 Feb; 20(1):13. PubMed ID: 29426360
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Costs and Effects of Implementing Digital Tomosynthesis in a Population-Based Breast Cancer Screening Program: Predictions Using Results from the To-Be Trial in Norway.
    Moger TA; Holen Å; Hanestad B; Hofvind S
    Pharmacoecon Open; 2022 Jul; 6(4):495-507. PubMed ID: 35796950
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Impact of specificity on cost-effectiveness of screening women at high risk of breast cancer with magnetic resonance imaging, mammography and ultrasound.
    Kaiser CG; Dietzel M; Vag T; Rübenthaler J; Froelich MF; Tollens F
    Eur J Radiol; 2021 Apr; 137():109576. PubMed ID: 33556759
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cost-Effectiveness of Digital Breast Tomosynthesis vs. Abbreviated Breast MRI for Screening Women with Intermediate Risk of Breast Cancer-How Low-Cost Must MRI Be?
    Tollens F; Baltzer PAT; Dietzel M; Rübenthaler J; Froelich MF; Kaiser CG
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33808955
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Value Analysis of Digital Breast Tomosynthesis for Breast Cancer Screening in a US Medicaid Population.
    Miller JD; Bonafede MM; Herschorn SD; Pohlman SK; Troeger KA; Fajardo LL
    J Am Coll Radiol; 2017 Apr; 14(4):467-474.e5. PubMed ID: 28139412
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme--a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with digital mammography alone.
    Gilbert FJ; Tucker L; Gillan MG; Willsher P; Cooke J; Duncan KA; Michell MJ; Dobson HM; Lim YY; Purushothaman H; Strudley C; Astley SM; Morrish O; Young KC; Duffy SW
    Health Technol Assess; 2015 Jan; 19(4):i-xxv, 1-136. PubMed ID: 25599513
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of Breast Cancer Risk Predictive Models and Screening Strategies for Chinese Women.
    Zhao Y; Xiong P; McCullough LE; Miller EE; Li H; Huang Y; Zhao M; Wang MJ; Kang M; Wang Q; Li JY
    J Womens Health (Larchmt); 2017 Mar; 26(3):294-302. PubMed ID: 28263689
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cumulative Probability of False-Positive Results After 10 Years of Screening With Digital Breast Tomosynthesis vs Digital Mammography.
    Ho TH; Bissell MCS; Kerlikowske K; Hubbard RA; Sprague BL; Lee CI; Tice JA; Tosteson ANA; Miglioretti DL
    JAMA Netw Open; 2022 Mar; 5(3):e222440. PubMed ID: 35333365
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The cost-effectiveness of non-invasive stool-based colorectal cancer screening offerings from age 45 for a commercial and medicare population.
    Ebner D; Kisiel J; Barnieh L; Sharma R; Smith NJ; Estes C; Vahdat V; Ozbay AB; Limburg P; Fendrick AM
    J Med Econ; 2023; 26(1):1219-1226. PubMed ID: 37752872
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cost-effectiveness of Low-Dose Computed Tomography With a Plasma-Based Biomarker for Lung Cancer Screening in China.
    Zhao Z; Wang Y; Wu W; Yang Y; Du L; Dong H
    JAMA Netw Open; 2022 May; 5(5):e2213634. PubMed ID: 35608858
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.
    Manchanda R; Legood R; Burnell M; McGuire A; Raikou M; Loggenberg K; Wardle J; Sanderson S; Gessler S; Side L; Balogun N; Desai R; Kumar A; Dorkins H; Wallis Y; Chapman C; Taylor R; Jacobs C; Tomlinson I; Beller U; Menon U; Jacobs I
    J Natl Cancer Inst; 2015 Jan; 107(1):380. PubMed ID: 25435542
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cost-Effectiveness Analysis of Screening for Pancreatic Cancer Among High-Risk Populations.
    Peters MLB; Eckel A; Seguin CL; Davidi B; Howard DH; Knudsen AB; Pandharipande PV
    JCO Oncol Pract; 2024 Feb; 20(2):278-290. PubMed ID: 38086003
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma.
    Lee L; Pintilie M; Hodgson DC; Goss PE; Crump M
    Ann Oncol; 2008 Jan; 19(1):62-7. PubMed ID: 17878177
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis.
    Nahon P; Najean M; Layese R; Zarca K; Segar LB; Cagnot C; Ganne-Carrié N; N'Kontchou G; Pol S; Chaffaut C; Carrat F; Ronot M; Audureau E; Durand-Zaleski I; ; ; ;
    JHEP Rep; 2022 Jan; 4(1):100390. PubMed ID: 34977518
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines.
    Ahern CH; Shen Y
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):718-25. PubMed ID: 19258473
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cost-effectiveness of using artificial intelligence versus polygenic risk score to guide breast cancer screening.
    Mital S; Nguyen HV
    BMC Cancer; 2022 May; 22(1):501. PubMed ID: 35524200
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.
    Schousboe JT; Kerlikowske K; Loh A; Cummings SR
    Ann Intern Med; 2011 Jul; 155(1):10-20. PubMed ID: 21727289
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A modelling study to evaluate the costs and effects of lowering the starting age of population breast cancer screening.
    Koleva-Kolarova RG; Daszczuk AM; de Jonge C; Abu Hantash MK; Zhan ZZ; Postema EJ; Feenstra TL; Pijnappel RM; Greuter MJW; de Bock GH
    Maturitas; 2018 Mar; 109():81-88. PubMed ID: 29452787
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Imaging Surveillance of Breast Cancer Survivors with Digital Mammography versus Digital Breast Tomosynthesis.
    Bahl M; Mercaldo S; McCarthy AM; Lehman CD
    Radiology; 2021 Feb; 298(2):308-316. PubMed ID: 33350890
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cost-Effectiveness of Colonoscopy-Based Colorectal Cancer Screening in Childhood Cancer Survivors.
    Gini A; Meester RGS; Keshavarz H; Oeffinger KC; Ahmed S; Hodgson DC; Lansdorp-Vogelaar I
    J Natl Cancer Inst; 2019 Nov; 111(11):1161-1169. PubMed ID: 30980665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.